Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events
Domains
Bioinformatics [q-bio.QM]| Origin | Files produced by the author(s) |
|---|
Journal Articles
European Journal of Cancer
Year : 2021
Accord Elsevier CCSD : Connect in order to contact the contributor
https://hal.science/hal-03671495
Submitted on : Monday, October 16, 2023-1:31:33 PM
Last modification on : Wednesday, October 30, 2024-6:08:04 PM
Long-term archiving on : Wednesday, January 17, 2024-8:23:25 PM
Dates and versions
Licence
Identifiers
- HAL Id : hal-03671495 , version 1
- DOI : 10.1016/j.ejca.2021.08.036
- PII : S0959-8049(21)00567-0
Cite
Marie Kostine, Eleonora Mauric, Alice Tison, Thomas Barnetche, Aurélien Barre, et al.. Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events. European Journal of Cancer, 2021, 157, pp.474-484. ⟨10.1016/j.ejca.2021.08.036⟩. ⟨hal-03671495⟩
Collections
94
View
34
Download